Companies House does not verify the accuracy of the information filed

ODYSSEY THERAPEUTICS UK LIMITED

Company number 11609778

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
18 Oct 2021	AP01	Appointment of Dr Valerie Odegard as a director on 6 October 2021	View PDF Appointment of Dr Valerie Odegard as a director on 6 October 2021 - link opens in a new window - 2 pages (2 pages)
18 Oct 2021	AP01	Appointment of Ms Jill Anne Carroll as a director on 6 October 2021	View PDF Appointment of Ms Jill Anne Carroll as a director on 6 October 2021 - link opens in a new window - 2 pages (2 pages)
18 Oct 2021	AP01	Appointment of Mr Charles Baum as a director on 6 October 2021	View PDF Appointment of Mr Charles Baum as a director on 6 October 2021 - link opens in a new window - 2 pages (2 pages)
18 Oct 2021	AP01	Appointment of Mr Gary Glick as a director on 6 October 2021	View PDF Appointment of Mr Gary Glick as a director on 6 October 2021 - link opens in a new window - 2 pages (2 pages)
18 Oct 2021	TM01	Termination of appointment of Leonard Peter Wossnig as a director on 6 October 2021	View PDF Termination of appointment of Leonard Peter Wossnig as a director on 6 October 2021 - link opens in a new window - 1 page (1 page)
18 Oct 2021	TM01	Termination of appointment of Edward Nikolas Grant as a director on 6 October 2021	View PDF Termination of appointment of Edward Nikolas Grant as a director on 6 October 2021 - link opens in a new window - 1 page (1 page)
18 Oct 2021	TM01	Termination of appointment of Robert Ian Horobin as a director on 6 October 2021	View PDF Termination of appointment of Robert Ian Horobin as a director on 6 October 2021 - link opens in a new window - 1 page (1 page)
18 Oct 2021	PSC02	Notification of Odyssey Therapeutics Inc. as a person with significant control on 6 October 2021	View PDF Notification of Odyssey Therapeutics Inc. as a person with significant control on 6 October 2021 - link opens in a new window - 2 pages (2 pages)
18 Oct 2021	PSC07	Cessation of Edward Nikolas Grant as a person with significant control on 6 October 2021	View PDF Cessation of Edward Nikolas Grant as a person with significant control on 6 October 2021 - link opens in a new window - 1 page (1 page)
18 Oct 2021	PSC07	Cessation of Leonard Peter Wossnig as a person with significant control on 6 October 2021	View PDF Cessation of Leonard Peter Wossnig as a person with significant control on 6 October 2021 - link opens in a new window - 1 page (1 page)
27 Sep 2021	AA	Total exemption full accounts made up to 31 December 2020	View PDF Total exemption full accounts made up to 31 December 2020 - link opens in a new window - 8 pages (8 pages) Download iXBRL
15 Oct 2020	CS01	Confirmation statement made on 7 October 2020 with updates	View PDF Confirmation statement made on 7 October 2020 with updates - link opens in a new window - 5 pages (5 pages)
30 Jun 2020	AA	Total exemption full accounts made up to 31 December 2019	View PDF Total exemption full accounts made up to 31 December 2019 - link opens in a new window - 9 pages (9 pages) Download iXBRL
08 Oct 2019	CS01	Confirmation statement made on 7 October 2019 with updates	View PDF Confirmation statement made on 7 October 2019 with updates - link opens in a new window - 6 pages (6 pages)
02 Sep 2019	AD01	Registered office address changed from 3 Weekley Wood Close Kettering Northamptonshire NN14 1UQ United Kingdom to Clifton House 46 Clifton Terrace Finsbury Park Greater London N4 3JP on 2 September 2019	View PDF Registered office address changed from 3 Weekley Wood Close Kettering Northamptonshire NN14 1UQ United Kingdom to Clifton House 46 Clifton Terrace Finsbury Park Greater London N4 3JP on 2 September 2019 - link opens in a new window - 1 page (1 page)
25 Jul 2019	SH01	Statement of capital following an allotment of shares on 20 June 2019 GBP 78.270	View PDF Statement of capital following an allotment of shares on 20 June 2019 GBP 78.270 - link opens in a new window - 6 pages (6 pages)
17 Jul 2019	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	View PDF Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association - link opens in a new window - 52 pages (52 pages)
17 May 2019	RESOLUTIONS	Resolutions RES13 ‐ Sub divison 01/05/2019	View PDF Resolutions RES13 ‐ Sub divison 01/05/2019 - link opens in a new window - 1 page (1 page)
15 May 2019	SH02	Sub-division of shares on 1 May 2019	View PDF Sub-division of shares on 1 May 2019 - link opens in a new window - 4 pages (4 pages)
13 May 2019	AA01	Current accounting period extended from 31 October 2019 to 31 December 2019	View PDF Current accounting period extended from 31 October 2019 to 31 December 2019 - link opens in a new window - 1 page (1 page)
01 May 2019	SH01	Statement of capital following an allotment of shares on 1 May 2019 GBP 59	View PDF Statement of capital following an allotment of shares on 1 May 2019 GBP 59 - link opens in a new window - 3 pages (3 pages)
08 Oct 2018	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2018-10-08 GBP 57	View PDF Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2018-10-08 GBP 57 - link opens in a new window - 35 pages (35 pages)

Cookies on Companies House services

ODYSSEY THERAPEUTICS UK LIMITED

Filter by category